242 related articles for article (PubMed ID: 34938806)
1. AEBP1 Is One of the Epithelial-Mesenchymal Transition Regulatory Genes in Colon Adenocarcinoma.
Li D; Liu Z; Ding X; Qin Z
Biomed Res Int; 2021; 2021():3108933. PubMed ID: 34938806
[TBL] [Abstract][Full Text] [Related]
2. AEBP1, a prognostic indicator, promotes colon adenocarcinoma cell growth and metastasis through the NF-κB pathway.
Xing Y; Zhang Z; Chi F; Zhou Y; Ren S; Zhao Z; Zhu Y; Piao D
Mol Carcinog; 2019 Oct; 58(10):1795-1808. PubMed ID: 31219650
[TBL] [Abstract][Full Text] [Related]
3. AEBP1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the NF-κB pathway and predicts poor outcome of the patients.
Liu JY; Jiang L; Liu JJ; He T; Cui YH; Qian F; Yu PW
Sci Rep; 2018 Aug; 8(1):11955. PubMed ID: 30097586
[TBL] [Abstract][Full Text] [Related]
4. AEBP1 promotes papillary thyroid cancer progression by activating BMP4 signaling.
Ju G; Xing T; Xu M; Zhang X; Sun Y; Mu Z; Sun D; Miao S; Li L; Liang J; Lin Y
Neoplasia; 2024 Mar; 49():100972. PubMed ID: 38237535
[TBL] [Abstract][Full Text] [Related]
5. Identification of extracellular matrix-related biomarkers in colon adenocarcinoma by bioinformatics and experimental validation.
Yin Y; Yang X; Cheng Z; Wang H; Lei J; Wang D; Wang P; Li B; Mi J; Yuan Q
Front Immunol; 2024; 15():1371584. PubMed ID: 38694509
[TBL] [Abstract][Full Text] [Related]
6. The transcriptome signature analysis of the epithelial-mesenchymal transition and immune cell infiltration in colon adenocarcinoma.
Heryanto YD; Imoto S
Sci Rep; 2023 Oct; 13(1):18383. PubMed ID: 37884639
[TBL] [Abstract][Full Text] [Related]
7. The Invasion and Metastasis of Colon Adenocarcinoma (COAD) Induced by SALL4.
Zhang W; Hu Y; Zhang W; Yi K; Xu X; Chen Z
J Immunol Res; 2022; 2022():9385820. PubMed ID: 35692499
[TBL] [Abstract][Full Text] [Related]
8. Collagen-rich stroma in aggressive colon tumors induces mesenchymal gene expression and tumor cell invasion.
Vellinga TT; den Uil S; Rinkes IH; Marvin D; Ponsioen B; Alvarez-Varela A; Fatrai S; Scheele C; Zwijnenburg DA; Snippert H; Vermeulen L; Medema JP; Stockmann HB; Koster J; Fijneman RJ; de Rooij J; Kranenburg O
Oncogene; 2016 Oct; 35(40):5263-5271. PubMed ID: 26996663
[TBL] [Abstract][Full Text] [Related]
9. A Risk Model for Prognosis and Treatment Response Prediction in Colon Adenocarcinoma Based on Genes Associated with the Characteristics of the Epithelial-Mesenchymal Transition.
Huang H; Li T; Meng Z; Zhang X; Jiang S; Suo M; Li N
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686013
[TBL] [Abstract][Full Text] [Related]
10. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
[TBL] [Abstract][Full Text] [Related]
11. PLOD3 Is Associated with Immune Cell Infiltration and Genomic Instability in Colon Adenocarcinoma.
Deng X; Pan Y; Yang M; Liu Y; Li J
Biomed Res Int; 2021; 2021():4714526. PubMed ID: 34239923
[TBL] [Abstract][Full Text] [Related]
12. An epithelial-mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma.
Zhang Y; Li Y; Zuo Z; Li T; An Y; Zhang W
Pathol Oncol Res; 2023; 29():1611016. PubMed ID: 36910014
[No Abstract] [Full Text] [Related]
13. Annexin A1 Expression Is Associated with Epithelial-Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer.
Oshi M; Tokumaru Y; Mukhopadhyay S; Yan L; Matsuyama R; Endo I; Takabe K
Cells; 2021 Mar; 10(3):. PubMed ID: 33804148
[TBL] [Abstract][Full Text] [Related]
14. SUFU mediates EMT and Wnt/β-catenin signaling pathway activation promoted by miRNA-324-5p in human gastric cancer.
Peng Y; Zhang X; Lin H; Deng S; Qin Y; Yuan Y; Feng X; Wang J; Chen W; Hu F; Yan R; Zhao Y; Cheng Y; Wei Y; Fan X; Ashktorab H; Smoot D; Li S; Meltzer SJ; Jin Z
Cell Cycle; 2020 Oct; 19(20):2720-2733. PubMed ID: 33017570
[TBL] [Abstract][Full Text] [Related]
15. miR-22 and miR-214 targeting BCL9L inhibit proliferation, metastasis, and epithelial-mesenchymal transition by down-regulating Wnt signaling in colon cancer.
Sun R; Liu Z; Han L; Yang Y; Wu F; Jiang Q; Zhang H; Ma R; Miao J; He K; Wang X; Zhou D; Huang C
FASEB J; 2019 Apr; 33(4):5411-5424. PubMed ID: 30698996
[TBL] [Abstract][Full Text] [Related]
16. Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer.
Kan JY; Yen MC; Wang JY; Wu DC; Chiu YJ; Ho YW; Kuo PL
Oncotarget; 2016 May; 7(21):31336-49. PubMed ID: 27150059
[TBL] [Abstract][Full Text] [Related]
17. Adipocyte enhancer binding protein 1 (AEBP1) knockdown suppresses human glioma cell proliferation, invasion and induces early apoptosis.
Cheng L; Shao X; Wang Q; Jiang X; Dai Y; Chen S
Pathol Res Pract; 2020 Feb; 216(2):152790. PubMed ID: 31864713
[TBL] [Abstract][Full Text] [Related]
18. Deubiquitinase BRCC3 promotes the migration, invasion and EMT progression of colon adenocarcinoma by stabilizing MET expression.
Feng X; He S; Chen Y; Zhang L
Genes Genomics; 2024 May; 46(5):637-646. PubMed ID: 38470543
[TBL] [Abstract][Full Text] [Related]
19. Identification of prognostic stemness biomarkers in colon adenocarcinoma drug resistance.
Li Z; Chen J; Zhu D; Wang X; Chen J; Zhang Y; Lian Q; Gu B
BMC Genom Data; 2022 Jul; 23(1):51. PubMed ID: 35794546
[TBL] [Abstract][Full Text] [Related]
20. Integrative multi-omics analysis of a colon cancer cell line with heterogeneous Wnt activity revealed RUNX2 as an epigenetic regulator of EMT.
Yi H; Li G; Long Y; Liang W; Cui H; Zhang B; Tan Y; Li Y; Shen L; Deng D; Tang Y; Mao C; Tian S; Cai Y; Zhu Q; Hu Y; Chen W; Fang L
Oncogene; 2020 Jul; 39(28):5152-5164. PubMed ID: 32535615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
